Horizon Pharma (HZNP) Reports In-Line Q1 EPS; Lifts FY15 Revenue Outlook

Horizon Pharma (NASDAQ: HZNP) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $113.1 million versus the consensus estimate of $104.2 million.

Horizon Pharma sees FY2015 revenue of $590-610 million, versus prior guidance of $450-475 million and the consensus of $538.8 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• SuperCom (SPCB) Tops Q3 EPS by 43c
• Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c